TMPRSS2-ERG Fusion Identified by Comprehensive Genomic Profiling Reveals Prostatic Origin in Cancer of Unknown

Koji Hikino1, Wataru Naito2, Shinichi Teshima2

  • 1Department of Clinical Oncology, Shonan Kamakura General Hospital, Kamakura, JPN.

Cureus
|May 7, 2026
PubMed
Summary

Comprehensive genomic profiling aids in identifying the origin of cancer of unknown primary (CUP). This approach detected a TMPRSS2-ERG fusion, confirming prostate cancer in a patient with metastatic disease.